Dear Doctor Letter (Rote-Hand-Brief) on Samsca® (tolvaptan): liver injury
2013.05.23
Active substance: tolvaptan
Information for healthcare professionals regarding the potential risk of liver injury due to Samsca® (tolvaptan).
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN